Sign in

NCT06518642Completed

Transcranial Direct Current Stimulation (tDCS) in Young Individuals with Major Depressive Disorder: a Literature Review and Feasibility Study

Source: ClinicalTrials.gov · Last updated 27 Nov 2024

Brief summary (registry, in English)

Objectives: (1) To assess the therapeutic effects of tDCS on improving depressive symptoms in young individuals with Major Depressive Disorder (MDD), relative to sham stimulation ; and (2) to evaluate the tolerability, and feasibility of tDCS in young individuals with Major Depressive Disorder, to explore the feasibility for a scale-up study. Hypothesis: 1) we hypothesize the tDCS stimulation of the dorsolateral prefrontal cortex (dLPFC) will reduce symptoms of depression more than sham stimulation, demonstrated by significant difference in change of Hamilton Depression Rating Scale (HDRS) and 2) tDCS active stimulation of the dLPFC will be tolerable and feasible among patients with MDD, as demonstrated by minimal adverse effects measured in the Adverse Events Questionnaire, adherence (with reasons of drop out), their motivation and enjoyment to participate in the study .

Status (registry)
Completed
Study type
Interventional
Enrollment
8 (actual)
First submitted
18 Jul 2024
Start date
31 Jul 2024
Primary completion date
31 Oct 2024
Lead sponsor
The University of Hong Kong
Diseases
Depression
NCT number
NCT06518642

What you commit to

  • Study type: Interventional
  • Participants enrolled: 8
  • From 31 Jul 2024 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant unstable medical conditions; major neurological conditions;

Other illness

  • History of significant head trauma, neurological disorders (e.g., epilepsy), seizures;
  • First degree relative with epilepsy;
  • Comorbid disorders listed in the DSM-V, e.g., schizophrenia, substance use disorder, mental retardation, etc.;
  • Device or metal clips on or inside the skull, cardiac pacemaker;

Other

  • Pregnancy, lactating women, or women planning pregnancy;
  • Inability to provide informed consent.

Who the study is looking for

  • Diagnosed with major depressive disorder (MDD) according to the Structured Clinical Interview for DSM-5, Clinical Version (SCID-DSM-5, CV)
  • Scored ≥ 14 (i.e., at least mild to moderate depression on the 17-item Hamilton Depression Rating Scale (HDRS) at screening and at baseline;
  • Right handedness;
  • Stable dosage of antidepressants or other treatments for depression in recent 4 weeks; and
  • Can read and write Chinese.

Age in the registry: 16 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Hong Kong
Coordinator of this site? Confirm its status
Hong KongHong KongUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.